Loading organizations...
Loading organizations...
Clinical-stage biopharmaceutical company developing allergy treatments.
Worg Pharmaceuticals has raised $194.2M across 2 funding rounds.
Worg Pharmaceuticals has raised $194.2M in total across 2 funding rounds.
Worg Pharmaceuticals has raised $194.2M in total across 2 funding rounds.
Worg Pharmaceuticals's investors include LongRiver Investments, Wuxi Guolian Jintou Zhiyuan.
Worg Pharmaceuticals has raised $194.2M across 2 funding rounds. Most recently, it raised $42.6M Series D in December 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 23, 2025 | $42.6M Series D | LongRiver Investments, Wuxi Guolian Jintou Zhiyuan | |
| Jun 30, 2023 | $151.6M Series C |